Madiha Derouazi
Hoofd Techniek/Wetenschap/O&O bij AC IMMUNE SA
Vermogen: 7 271 $ op 30-04-2024
Actieve functies van Madiha Derouazi
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AC IMMUNE SA | Hoofd Techniek/Wetenschap/O&O | 01-01-2024 | - |
Amal Therapeutics SA
Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Directeur/Bestuurslid | 03-09-2012 | - |
Algemeen Directeur | 03-09-2012 | - | |
Oprichter | 03-09-2012 | - |
Loopbaan van Madiha Derouazi
Eerdere bekende functies van Madiha Derouazi
Bedrijven | Functie | Begin | Einde |
---|
Opleiding van Madiha Derouazi
Technical University of Berlin | Graduate Degree |
Swiss Federal Institute of Technology | Doctorate Degree |
Statistieken
Internationaal
Zwitserland | 3 |
Duitsland | 3 |
Operationeel
Chief Executive Officer | 2 |
Director/Board Member | 1 |
Founder | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AC IMMUNE SA | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Amal Therapeutics SA
Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Health Technology |
- Beurs
- Insiders
- Madiha Derouazi
- Ervaring